Position history for First Command Advisory Services, Inc.'s holdings in Arcutis Biotherapeutics, Inc.
First Command Advisory Services, Inc. holds 2,000 shares of ARQT (Arcutis Biotherapeutics, Inc.), worth $58,080 as of 2025-Q4. ARQT represents 0.0% of First Command Advisory Services, Inc.'s portfolio.
Current Value
$58,080
Current Shares
2,000
Total Value Change
+$38,260
Total Shares Change
0
Other major holders of ARQT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Unchanged |
| 2,000 |
0.0% |
| $58,080 |
| 0.0% |
| $28.08 |
0 |
| 2025-Q3 | Unchanged | 2,000 | 0.0% | $37,700 | 0.0% | $18.62 | 0 |
| 2025-Q2 | Unchanged | 2,000 | 0.0% | $28,040 | 0.0% | $13.74 | 0 |
| 2025-Q1 | Unchanged | 2,000 | 0.0% | $31,280 | 0.0% | $15.73 | 0 |
| 2024-Q4 | Unchanged | 2,000 | 0.0% | $27,860 | 0.0% | $14.20 | 0 |
| 2024-Q3 | Unchanged | 2,000 | 0.0% | $18,600 | 0.0% | $9.36 | 0 |
| 2024-Q2 | Unchanged | 2,000 | 0.0% | $18,600 | 0.0% | $9.30 | 0 |
| 2024-Q1 | Unchanged | 2,000 | 0.0% | $19,820 | 0.0% | $9.91 | 0 |